How Do I Know if a Peptide Company Is Legit?

Published August 27, 2026 · Artemis Labs

Research Buyer FAQ › Choosing a Peptide Supplier & the Enforcement Record › Verifying a Supplier

You verify a peptide company with documents, not marketing. Six checks — independent testing, lot-specific paperwork, citations you can follow, honest negative findings, no administration supplies, published policies — can all be run before you spend anything. They apply to every vendor, Artemis Labs included. Never take a vendor’s own page as the verdict on that vendor.

How this page was built. The checks below are drawn from the documented enforcement record of 2024–2026 — the things regulators and courts actually cited — not from a marketing department’s idea of trust. Dates and case facts trace to the agency or court record via the linked write-ups. Sources are under References.

How do I know if a peptide company is legit?

You check what can be checked, and you weigh silence as an answer. Every serious question about a vendor has a document behind it: who tests the material, what a specific lot measured, where a claim comes from, what the published policies say. A vendor who can produce those documents may still be worth scrutiny. A vendor who cannot has already answered you.

The reason to be this cold about it is recent and concrete. Between 2024 and 2026 several of the largest names in this market closed, were raided, or ended up in federal court — the dated chronology is in our record of 2025–2026 vendor closures. Buyers who chose on marketing lost suppliers overnight, sometimes with orders pending. Buyers who chose on documents had, at minimum, seen the warning signs listed on this page.

What is the most trusted peptide company?

There is no honest answer in the form of a name, and a page that gives one is doing marketing, not verification. No published ranking of peptide vendors verifies the testing claims behind it — “most trusted” and “most legit” lists are typically affiliate content — and trust in this market has a short shelf life: several of the biggest names of 2024 were gone by 2026, as the enforcement record below sets out. The answerable version of the question is the one this page exists for: which vendor can produce the documents? Run the six checks that follow on any company you are considering — Artemis Labs included, with no discount for the fact that you are reading them here. A vendor that passes them today, on the lot in front of you, is as close to “most trusted” as this market honestly gets.

What are the six checks?

Each one can be run from public information or from a single order, before any real money moves.

  1. Independent testing. Ask who tests the material and whether that lab is independent of the seller. HPLC is the standard method for putting a number on purity, and mass spectrometry confirms identity — the glossary entry for HPLC covers what the method does and does not show.
  2. Lot-specific paperwork. A Certificate of Analysis should match the lot code on the vial in front of you, not exist only as a sample image on a product page. A document that cannot be tied to your vial verifies nothing.
  3. Citations you can follow. Research claims should link to the published record — journal, PubMed, DOI — so you can read what was actually found, in what model.
  4. Honest negative findings. The published literature contains results that cut against every popular compound. A vendor who surfaces those is showing you how they handle inconvenient facts. A vendor whose pages contain only good news has made an editorial choice you should price in.
  5. No administration supplies. In its March 31, 2026 warning letters the FDA cited administration supplies sold alongside research products as evidence the products were intended as drugs for human use. A research supplier has no reason to sell them, and their presence in a catalog is a regulatory finding waiting to happen.
  6. Published policies. Shipping, refund and terms pages you can read before checkout. Their absence tells you how disputes will go.

The worked version of this list, with examples of good and bad answers, is the peptide supplier evaluation checklist.

Why does the enforcement record change how you shop?

Because it shows which failures actually end vendors, and none of them were about price or selection. Peptide Sciences — the largest US vendor — announced its closure on March 6, 2026, and its own notice stated that any further sales under its brand are fraudulent; unaffiliated sites reusing the branding appeared afterward, which is why our write-up on unaffiliated sites reusing Peptide Sciences branding exists. The FDA’s warning letters, batch after batch, turned on what vendors’ own websites said and sold — the letter-by-letter breakdown is in the April 2026 FDA warning-letter batch.

The pattern across all of it: the sites that got hit looked helpful. The material regulators quoted was marketing that promised things and catalogs that sold convenience. So the record inverts the usual instinct. In this market, the vendor that answers every question and sells every accessory is not the safe choice. It is the one with the shortest expected lifespan, and your pending order shares that lifespan.

Should you ask whether a vendor tests every lot?

Yes, and the follow-up matters more than the first answer. Any vendor will say yes to “do you test.” The verifiable version has three parts: which lab, on which lots, and can you see the report for the lot code on your vial. Per-lot testing that cannot be tied to your lot is a claim about other people’s vials.

Notice what this check does not require: trust. You are not asking the vendor to be honest. You are asking for an artifact that would be hard to produce dishonestly at scale — though not impossible, which is why the document itself gets audited too. Forged certificates are part of the documented record in this market, and the red-flag patterns are covered on the parent page under Choosing a Peptide Supplier & the Enforcement Record.

How should you apply these checks to Artemis Labs?

Exactly as written, with no discount for the fact that you are reading them here. This page is the vendor talking, and a vendor’s own trust page is the last place to suspend the checklist. So run it on us. Follow our citations to their sources and see whether they say what our pages say. Look at whether we sell administration supplies. Read the policies linked from the footer before you order.

And on testing documentation, hold us to the same standard as everyone else: as of the date on this page, Artemis Labs does not publish lot-testing documentation on this site. Until a document with a lot number that matches a vial is in front of you, count any testing claim from us as unverified — the same way this page tells you to count one from anyone else. A checklist that exempts its author is marketing. This one does not.

What does a bad answer sound like?

Vague, deflecting, or oddly generous. “Our products are the purest available” with no document is a slogan. “The lab is proprietary” means the lab cannot be checked. “That information is available on request” followed by silence is the answer. And detailed helpfulness about things a research supplier should not discuss at all is the strangest tell of the set — it reads as customer service and is actually the clearest signal of how the vendor operates, because it is precisely what the enforcement record shows regulators reading first.

The scam patterns that follow from failed verification — forged documents, lookalike sites, missing lot numbers — are covered on the parent page, Choosing a Peptide Supplier & the Enforcement Record, along with the full vendor-by-vendor chronology. This page is one section of the full Artemis Labs research-buyer FAQ.

References

  1. US FDA — Warning Letters database, including the December 10, 2024 batch and the March 31, 2026 batch (seven sites, posted April 7, 2026). fda.gov warning letters database
  2. Artemis Labs — “Peptide Vendor Closures 2025–2026,” dated chronology with primary sources. artemispeptides.com/blog/peptide-vendor-closures-2025-2026/
  3. CBS News — “Peptides seller sentenced to prison for selling unapproved drugs” (Paradigm Peptides; pleas December 10, 2025; sentencing July 30, 2026, N.D. Indiana). cbsnews.com

All compounds sold by Artemis Labs are for laboratory research use only. Nothing on this page is medical advice, and no statement has been evaluated by the FDA.